Navigation Links
First Comprehensive Reference on Evidence-Based Design Published
Date:6/4/2008

ections have been linked to hospital stays. Malkin discusses the characteristics of pathogens and how infections spread and what implications these have for design professionals. She cites studies indicating that infection rates are lower in properly designed and ventilated private rooms as compared to multi-bed rooms and that medication errors are reduced. Fewer infections, fewer medication errors translate into shorter length of stay and lower costs. And, while the focus of the book is primarily on what benefits patients and their family members, there's evidence that caregivers perform better in an environment that relieves stress.

Attention is given to the ways in which lighting, ceiling, acoustics, views of the natural landscape and artwork can enhance the patient experience. Included, too, are analyses of lobby design, waiting areas, patient units, patient and family amenities, and to a lesser extent on caregiver lounges, diagnostic centers, and treatment areas for cancer. Appearing in case study format are innovative facilities that illustrate a new path in their design approach. Over 300 color photos and planning layouts accompanied by insightful commentary illustrate EBD projects at more than 70 facilities throughout the U.S., including Jay Monahan Center for Gastrointestinal Health, NY; Presbyterian Hospital/Weill Cornell Medical Center, NYC; Abbott Northwestern Heart Hospital, Minneapolis, MN; Florida Hospital, Orlando, FL; M.D. Anderson Cancer Center, Houston, TX; and Scripps Memorial Hospital, LaJolla, CA.

To order A Visual Reference for Evidence-Based Design online, visit http://www.healthdesign.org/book or call The Center for Health Design at 925.521.8404 weekdays 8:30-5 PDT.

*Source: Healthcare Facilities Management, 2008 Building Report, Feb. 2008.

With a grant from the Robert Wood Johnson Foundation, A Visual Reference for Evidence Based Design was published by
'/>"/>

SOURCE The Center For Health Design
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. First biomarker discovered that predicts prostate cancer outcome
2. FDA Approves First Anti-Psychotic for Kids
3. Single-incision belly-button surgery to remove kidney performed first at UT Southwestern
4. First study examines newly-licensed RN work attitudes and intentions
5. Glades General Hospital First in Palm Beach County to Provide On-Site Electronic Birth Registration
6. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
7. Father and Daughter From Tanzania Receive Their First Medical Examination in Newport Beach
8. High and mighty: first common height gene identified by researchers behind obesity gene finding
9. APA Comments on FDAs First Approval of Medication to Treat Pediatric Schizophrenia and Bipolar Disorder
10. TriWest Creates First-of-its-Kind Partnership to Offer Military Leaders With Grief Support Program
11. Watson Receives First FDA Approval for Manufacturing Product at Its Goa, India Facility
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Sanofi Pasteur Global Dengue Vaccine Clinical Program Expanded in Latin America 2Sanofi Pasteur Global Dengue Vaccine Clinical Program Expanded in Latin America 3Sanofi Pasteur Global Dengue Vaccine Clinical Program Expanded in Latin America 4Sanofi Pasteur Global Dengue Vaccine Clinical Program Expanded in Latin America 5Ascension Orthopedics Hires Key Senior Executives 2Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 2Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 3Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 4Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 5Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 6Akorn Inc Announces Third Quarter 2009 Earnings Release and Conference Call Information 60113 1Reportlinker Adds Bioinformatics and Computational Biology 3A Bottlenecks and Options 14598 1Reportlinker Adds Bioinformatics and Computational Biology 3A Bottlenecks and Options 14598 2Reportlinker Adds Bioinformatics and Computational Biology 3A Bottlenecks and Options 14598 3Reportlinker Adds Bioinformatics and Computational Biology 3A Bottlenecks and Options 14598 4Reportlinker Adds Bioinformatics and Computational Biology 3A Bottlenecks and Options 14598 5Reportlinker Adds Bioinformatics and Computational Biology 3A Bottlenecks and Options 14598 6Reportlinker Adds Bioinformatics and Computational Biology 3A Bottlenecks and Options 14598 7Reportlinker Adds Bioinformatics and Computational Biology 3A Bottlenecks and Options 14598 8Reportlinker Adds Bioinformatics and Computational Biology 3A Bottlenecks and Options 14598 9Reportlinker Adds Bioinformatics and Computational Biology 3A Bottlenecks and Options 14598 10Reportlinker Adds Bioinformatics and Computational Biology 3A Bottlenecks and Options 14598 11Medivation to Host Conference Call at 8 3A30 a m Eastern Time Tomorrow to Discuss Partnering Plans for MDV3100 14596 1